Skip to content
★ Sign in to follow
NF

Nigel Fleming

Executive
Impax Laboratories, LLC
Total declarations
44
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (22 ops.)
€2.7M

Latest filing published 01 Sept 2015 for Impax Laboratories, LLC, €225k.

Insider track record

Disclosed buys
0
Disclosed sells
22
Signal history

No signal scores available.

Nigel Fleming: trading record in brief

Nigel Fleming appears in our data through filings on Impax Laboratories, LLC shares, published by SEC (Form 4). We count 44 filings; the first trade dates from 20 May 2009 and the latest from 31 August 2015.

Every open-market trade on record is a sale: 22 sales worth €2.7M. The rest of the record consists of 7 share grants and 15 option exercises. Since January 2015: no purchases and 4 sales on the market.

Most recently, on 1 September 2015, the filings show an open-market sale worth €225k in Impax Laboratories, LLC. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Nigel Fleming

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations44 total

25 of 44 declarations